These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38763467)

  • 1. Comparison of exon-level copy number variants in CytoScan XON assay and next-generation sequencing in clinical samples.
    Won D; Yeom E; Shin S; Lee ST; Rak Choi J
    Clin Chim Acta; 2024 Jun; 560():119703. PubMed ID: 38763467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.
    Agaoglu NB; Unal B; Akgun Dogan O; Zolfagharian P; Sharifli P; Karakurt A; Can Senay B; Kizilboga T; Yildiz J; Dinler Doganay G; Doganay L
    Expert Rev Mol Diagn; 2022 Feb; 22(2):239-246. PubMed ID: 35240897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
    Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
    Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
    [No Abstract]   [Full Text] [Related]  

  • 5. Copy number variant detection using next-generation sequencing in EYS-associated retinitis pigmentosa.
    Hiraoka M; Urakawa Y; Kawai K; Yoshida A; Hosakawa J; Takazawa M; Inaba A; Yokota S; Hirami Y; Takahashi M; Ohara O; Kurimoto Y; Maeda A
    PLoS One; 2024; 19(6):e0305812. PubMed ID: 38913662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel.
    Chiang T; Liu X; Wu TJ; Hu J; Sedlazeck FJ; White S; Schaid D; Andrade M; Jarvik GP; Crosslin D; Stanaway I; Carrell DS; Connolly JJ; Hakonarson H; Groopman EE; Gharavi AG; Fedotov A; Bi W; Leduc MS; Murdock DR; Jiang Y; Meng L; Eng CM; Wen S; Yang Y; Muzny DM; Boerwinkle E; Salerno W; Venner E; Gibbs RA
    Genet Med; 2019 Sep; 21(9):2135-2144. PubMed ID: 30890783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data.
    Kang Y; Nam SH; Park KS; Kim Y; Kim JW; Lee E; Ko JM; Lee KA; Park I
    BMC Bioinformatics; 2018 Oct; 19(1):381. PubMed ID: 30326846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CNVs in NGS Data Using VS-CNV.
    Fortier N; Rudy G; Scherer A
    Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ICR96 exon CNV validation series: a resource for orthogonal assessment of exon CNV calling in NGS data.
    Mahamdallie S; Ruark E; Yost S; Ramsay E; Uddin I; Wylie H; Elliott A; Strydom A; Renwick A; Seal S; Rahman N
    Wellcome Open Res; 2017; 2():35. PubMed ID: 28630945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
    Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
    BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer.
    Moreno-Cabrera JM; Del Valle J; Feliubadaló L; Pineda M; González S; Campos O; Cuesta R; Brunet J; Serra E; Capellà G; Gel B; Lázaro C
    J Med Genet; 2022 Jan; 59(1):75-78. PubMed ID: 33219106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistent count region-copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data.
    Kim MJ; Lee S; Yun H; Cho SI; Kim B; Lee JS; Chae JH; Sun C; Park SS; Seong MW
    Genet Med; 2022 Mar; 24(3):663-672. PubMed ID: 34906491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.
    Nagano C; Nozu K; Morisada N; Yazawa M; Ichikawa D; Numasawa K; Kourakata H; Matsumura C; Tazoe S; Tanaka R; Yamamura T; Minamikawa S; Horinouchi T; Nakanishi K; Fujimura J; Sakakibara N; Nozu Y; Ye MJ; Kaito H; Iijima K
    Clin Exp Nephrol; 2018 Aug; 22(4):881-888. PubMed ID: 29372472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CoNVaDING: Single Exon Variation Detection in Targeted NGS Data.
    Johansson LF; van Dijk F; de Boer EN; van Dijk-Bos KK; Jongbloed JD; van der Hout AH; Westers H; Sinke RJ; Swertz MA; Sijmons RH; Sikkema-Raddatz B
    Hum Mutat; 2016 May; 37(5):457-64. PubMed ID: 26864275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.